Apple held a press conference today. They announced a watch that can cost over $10,000 if you’re feeling saucy. A gold laptop if you’re feeling Midas-y. And an extension of HealthKit called ResearchKit, which is why we’ve gathered here today.
ResearchKit is “an open source software framework that makes it easy for researchers and developers to create apps that could revolutionize medical studies, potentially transforming medicine forever.” You can learn more about it here. At its launch, ResearchKit includes a rollout of five (5) apps: one for asthma, parkinson’s disease, diabetes, breast cancer, and cardiovascular disease. Again, you can learn more about each of their apps on their ResearchKit landing page.
Of course, this isn’t the first time diabetes shared the spotlight of Apple’s grand stage, remember the iBGStar? But seeing diabetes get an early adoption along with four other prominent diseases is a big deal. The fact that major hospitals and research institutions are part of this collaboration is a big deal. All of this is a very big deal. There’s a genuine opportunity to significantly impact health outcomes if widespread adoption takes off. But, the adoption must be widespread.